Skip to main content
PAYS
NASDAQ Trade & Services

Paysign Reports Blowout Q2 2026 with 48% Revenue Growth, 387% Net Income Surge, and Strong Operating Cash Flow

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Positive
Importance info
9
Price
$10.11
Mkt Cap
$536.136M
52W Low
$3.08
52W High
$9.6
52W Position info
228% above low
Off High info
at 52W high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

PAYS has more than doubled off its 52-week low of $3.08.

Summary

Paysign reported outstanding Q2 2026 results with revenue up 48% and net income soaring 387%, alongside a strong positive shift in operating cash flow, confirming prior positive news.


Key Events · Earnings and Guidance · PAYS

  • Exceptional Q2 2026 Financial Performance

    Total revenues increased by 48.1% to $28.25 million, and net income surged by 386.9% to $6.76 million for the three months ended June 30, 2026, compared to the prior year period. Diluted EPS rose to $0.11 from $0.02.

  • Significant Operating Cash Flow Improvement

    Net cash provided by operating activities for the six months ended June 30, 2026, was $20.08 million, a substantial positive swing from net cash used of $2.39 million in the same period last year.

  • Non-Cash Gain from Earn-Out Termination

    The company recognized a $990,000 non-cash fair value adjustment due to a decrease in the contingent consideration liability related to the Gamma Innovation LLC acquisition, which was subsequently terminated as revenue targets were not met.

  • Board Authorized Stock Repurchase Program

    The Board authorized a $5 million stock repurchase program on May 8, 2026, expiring May 7, 2029. No shares were purchased under this program during Q2 2026.


Analysis · PAYS · Trade & Services

Paysign, Inc. delivered exceptional second-quarter 2026 financial results, confirming the strong performance indicated by a recent news release. The company achieved substantial revenue growth, primarily driven by its pharma patient affordability business, and a dramatic increase in net income. A significant positive swing in operating cash flow further strengthens the company's financial position. Additionally, the company recognized a non-cash gain from the termination of a contingent earn-out liability and has an active stock repurchase program authorized by the board. While recent insider selling is noted in the broader context, the official Q2 results demonstrate robust operational execution and financial health.

At the time of this filing, PAYS was trading at $10.11 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $536.1M. The 52-week trading range was $3.08 to $9.60. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PAYS - Latest Insights

PAYS
Aug 05, 2026, 4:52 PM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $9.68
Real-time Price: $10.09 info
Change: +$0.410 (+4%) info
Market Cap: $536.136M info
PAYS
May 13, 2026, 7:36 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $6.31
Real-time Price: $10.09 info
Change: +$3.79 (+60%) info
Market Cap: $536.136M info
PAYS
May 12, 2026, 4:20 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $6.65
Real-time Price: $10.09 info
Change: +$3.44 (+52%) info
Market Cap: $536.136M info
PAYS
May 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.31
Real-time Price: $10.09 info
Change: +$3.78 (+60%) info
Market Cap: $536.136M info
PAYS
Mar 26, 2026, 7:33 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $5.11
Real-time Price: $10.09 info
Change: +$4.98 (+97%) info
Market Cap: $536.136M info